Insider · CIK 0001907345
Gary K. Lee
Files at LYEL (Lyell Immunopharma, Inc.). First filing Aug 13, 2025, latest Nov 12, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LYEL: Lyell Immunopharma, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Lyell Immunopharma, Inc. | $2,230 138 shares | -1% | +127% from low-27% from high | |
| 30Weak | Lyell Immunopharma, Inc. | $15k 1,453 shares | -9% | +37% from low-66% from high | |
| 30Weak | Lyell Immunopharma, Inc. | $2,785 267 shares | -3% | +36% from low-66% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | LYEL Lyell Immunopharma, Inc. | SOpen-market sale Common Stock | -138 | $16.16 | $2,230 | 15,366 | Nov 12, 2025 |
| Oct 27, 2025 | LYEL Lyell Immunopharma, Inc. | AGrant or award Option (right to buy)derivative | +68,000 | $0.00 | $0 | 68,000 | Oct 29, 2025 |
| Aug 20, 2025 | LYEL Lyell Immunopharma, Inc. | AGrant or award Common Stock | +8,000 | $0.00 | $0 | 16,957 | Aug 22, 2025 |
| Aug 21, 2025 | LYEL Lyell Immunopharma, Inc. | SOpen-market sale Common Stock | -1,453 | $10.54 | $15k | 15,504 | Aug 22, 2025 |
| Aug 11, 2025 | LYEL Lyell Immunopharma, Inc. | SOpen-market sale Common Stock | -131 | $10.53 | $1,379 | 9,093 | Aug 13, 2025 |
| Aug 12, 2025 | LYEL Lyell Immunopharma, Inc. | SOpen-market sale Common Stock | -136 | $10.34 | $1,406 | 8,957 | Aug 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.